Alicia Foucourt

A novel DYRK1A (Dual specificity tyrosine phosphorylation‐regulated kinase 1A) inhibitor for the treatment of Alzheimer's disease: effect on Tau and amyloid pathologies <i>in vitro</i>

Séverine Coutadeur, Hélène Benyamine, Laurence Delalonde et al. · Journal of Neurochemistry · 2014 · 107 citations

Microwave-accelerated Dimroth rearrangement for the synthesis of 4-anilino-6-nitroquinazolines. Application to an efficient synthesis of a microtubule destabilizing agent

Alicia Foucourt, Carole Dubouilh‐Benard, Elizabeth Chosson et al. · Tetrahedron · 2010 · 64 citations

Microwave-accelerated Dimroth Rearrangement, Organic Chemistry, Efficient Synthesis +5

Design and Synthesis of Thiazolo[5,4-f]quinazolines as DYRK1A Inhibitors, Part I

Alicia Foucourt, Damien Hédou, Carole Dubouilh‐Benard et al. · Molecules · 2014 · 51 citations · Full text

Combinatorial Chemistry, Organic Chemistry, Microwave Irradiation +17

Design and Synthesis of Thiazolo[5,4-f]quinazolines as DYRK1A Inhibitors, Part II

Alicia Foucourt, Damien Hédou, Carole Dubouilh‐Benard et al. · Molecules · 2014 · 48 citations · Full text

Down Syndrome, Combinatorial Chemistry, Medicinal Chemistry +15

An Unusual Binding Model of the Methyl 9-Anilinothiazolo[5,4-<i>f</i>] quinazoline-2-carbimidates (EHT 1610 and EHT 5372) Confers High Selectivity for Dual-Specificity Tyrosine Phosphorylation-Regulated Kinases

A. Chaikuad, Julien Diharce, Martin Schröder et al. · Journal of Medicinal Chemistry · 2016 · 42 citations · Full text

Bioorganic Chemistry, Molecular Regulation, Molecular Biology +23